The Conversation (0)
tiziana life science
NASDAQ:TLSA
Chart
Detailed Quote
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for autoimmune and inflammatory diseases, degenerative diseases, and cancer-related to the liver. Its clinical pipeline includes drug assets for Crohn's Disease, COVID19, Secondary Progressive Multiple Sclerosis, and Hepatocellular Carcinoma. Its development pipeline includes Foralumab, Milciclib, Anti-IL6R, and Others. The company has a single reporting segment, which is the research and development of biotechnological & pharmaceutical products.
Featured Articles and Interviews
Aug 12, 2025
Top 5 Small-cap Biotech Stocks (Updated August 2025)
Apr 01, 2025
Top 5 Small-cap Biotech Stocks (Updated March 2025)
Press Releases
See More Press Releases
Alert Options
No alert set
INN Article Notification
Alert Option
You will be notified when this event occurs. No additional settings needed.